John Oyler

Chief Executive Officer, Director, BeOne Medicines Ltd.

Bought, 12 months

$0.0M

Sold, 12 months

$328M

Companies

Latest trade

Aug 12, 2026

Companies

BeOne Medicines Ltd.Chief Executive Officer, Director −$328M

Trades

ONC Sold 54,892 shares at $358.15 · planned $19.7M Aug 12

ONC Sold 70,907 shares at $361.90 · planned $25.7M Aug 11

ONC Sold 115,011 shares at $357.88 · planned $41.2M Aug 10

ONC Sold 61,397 shares at $317.67 · planned $19.5M Jul 21

ONC Sold 48,316 shares at $312.26 · planned $15.1M Jul 20

ONC Sold 64,628 shares at $312.00 · planned $20.2M Jul 17

ONC Sold 166,597 shares at $318.09 · planned $53.0M Jul 16

ONC Sold 116,557 shares at $311.94 · planned $36.4M Jul 15

ONC Sold 145,861 shares at $305.95 · planned $44.6M Jul 14

ONC Sold 48,520 shares at $304.35 · planned $14.8M Jul 13

ONC Sold 11,698 shares at $298.34 · planned $3.5M Jul 10

ONC Sold 3,410 shares at $273.78 $0.9M Jun 23

ONC Sold 3,693 shares at $265.55 $1.0M Jun 16

ONC Sold 1,949 shares at $257.24 $0.5M Jun 11

ONC Sold 4,940 shares at $270.55 $1.3M Jun 8

ONC Sold 24,369 shares at $302.87 · planned $7.4M Dec 16

ONC Sold 75,631 shares at $307.79 · planned $23.3M Dec 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.